Cervical dystonia and pain: Characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)

Journal of Neurology

Volumn 261, Issue 7, 2014, Pages 1309-1319

  Charles, P David ^a   Adler, Charles H ^b   Stacy, Mark ^c   Comella, Cynthia ^d   Jankovic, Joseph ^e   Manack Adams, Aubrey ^f   Schwartz, Marc ^g   Brin, Mitchell F ^f,h  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f ALLERGAN INC   (United States)

^g MedNet Solutions   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botulinum toxin; Cervical dystonia; Dystonia; Pain

Indexed keywords

BOTULINUM TOXIN A; ACETYLCHOLINE RELEASE INHIBITOR;

ADULT; ARTICLE; CERVICAL DYSTONIA; CERVICAL SPONDYLOSIS; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; TORONTO WESTERN SPASMODIC TORTICOLLIS RATING SCALE SEVERITY AND DISABILITY; TREATMENT OUTCOME; AGED; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; OBSERVATION; PAIN MEASUREMENT; PSYCHOLOGY; REGISTER; RETROSPECTIVE STUDY; STATISTICAL MODEL; TORTICOLLIS; UNITED STATES;

ACETYLCHOLINE RELEASE INHIBITORS; ADULT; AGED; BOTULINUM TOXINS, TYPE A; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBSERVATION; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; REGISTRIES; RETROSPECTIVE STUDIES; TORTICOLLIS; UNITED STATES;

EID: 84904986606     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7343-6     Document Type: Article

References (34)

1. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863-873. doi: 10.1002/mds.25475
2. Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T (2012) The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 27:1789-1796. doi: 10.1002/mds.25244
3. Phukan J, Albanese A, Gasser T, Warner T (2011) Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol 10:1074-1085. doi: 10.1016/s1474-4422(11)70232-0
4. Molho ES, Feustel PJ, Factor SA (1998) Clinical comparison of tardive and idiopathic cervical dystonia. Mov Disord 13:486-489. doi: 10.1002/mds.870130319
5. Rondot P, Marchand MP, Dellatolas G (1991) Spasmodic torticollis - review of 220 patients. Can J Neurol Sci 18:143-151
6. Ramirez-Castaneda J, Jankovic J (2013) Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel) 5:249-266. doi: 10.3390/toxins5020249
7. Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J (2013) Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 67:94-114. doi: 10.1016/j.toxicon.2012.12.004
8. Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324:1186-1194. doi: 10.1056/NEJM199104253241707
9. Jankovic J, Adler CH, Charles PD, Comella C, Stacy M, Schwartz M, Sutch SM, Brin MF, Papapetropoulos S (2011) Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE). BMC Neurol 11:140. doi: 10.1186/1471-2377-11-140
10. Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA (1978) Studies with pain rating scales. Ann Rheum Dis 37:378-381
11. Cleland JA, Childs JD, Whitman JM (2008) Psychometric properties of the Neck Disability Index and Numeric Pain Rating Scale in patients with mechanical neck pain. Arch Phys Med Rehabil 89:69-74. doi: 10.1016/j.apmr.2007.08.126
12. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9-19. doi: 10.1016/j.pain.2004.09.012
13. Fejer R, Jordan A, Hartvigsen J (2005) Categorising the severity of neck pain: establishment of cut-points for use in clinical and epidemiological research. Pain 119:176-182. doi: 10.1016/j.pain.2005.09.033
14. Zelman DC, Dukes E, Brandenburg N, Bostrom A, Gore M (2005) Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain 115:29-36. doi: 10.1016/j.pain.2005.01.028
15. Cano SJ, Warner TT, Linacre JM, Bhatia KP, Thompson AJ, Fitzpatrick R, Hobart JC (2004) Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58). Neurology 63:1629-1633
16. Consky E, Basinski A, Belle L, Ranawaya R, Lang AE (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rate reliability [abstract]. Neurology 40(Suppl 1):445
17. Lindeman R, Merenda P, Gold R (1980) Introduction to bivariate and multivariate analysis. Scott Foresman & Co, Glenview
18. Hochberg Y (1988) A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802
19. R Core Team (2013) R: a language and environment for statistical computing. R Foundation for Statistical Computing. http://www.R-project.org/. Accessed 25 June 2013
20. Grömping U (2006) Relative importance for linear regression in R: the package relaimpo. J Stat Softw 17:1-27
21. Muggeo VM (2003) Estimating regression models with unknown break-points. Stat Med 22:3055-3071. doi: 10.1002/sim.1545
22. Muggeo VM (2008) Segmented: an R package to fit regression models with broken-line relationships. R News 8(1):20-25
23. Jabbari B, Machado D (2011) Treatment of refractory pain with botulinum toxins - an evidence-based review. Pain Med 12:1594-1606. doi: 10.1111/j.1526-4637.2011.01245.x
24. Chan J, Brin MF, Fahn S (1991) Idiopathic cervical dystonia: clinical characteristics. Mov Disord 6:119-126. doi: 10.1002/mds.870060206
25. Charles D, Brashear A, Hauser RA, Li HI, Boo LM, Brin MF, for the CD 140 Study Group (2012) Efficacy, tolerability, and immunogenicity of onabotulinumtoxinA in a randomized, double-blind, placebo-controlled trial for cervical dystonia. Clin Neuropharmacol 35:208-214. doi: 10.1097/WNF. 0b013e31826538c7
26. ®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci 308:103-109. doi: 10.1016/j.jns.2011.05.041
27. Lew MF, Chinnapongse R, Zhang Y, Corliss M (2010) RimabotulinumtoxinB effects on pain associated with cervical dystonia: results of placebo and comparator-controlled studies. Int J Neurosci 120:298-300. doi: 10.3109/00207451003668408
28. Chinnapongse R, Pappert EJ, Evatt M, Freeman A, Birmingham W (2010) An open-label, sequential dose-escalation, safety, and tolerability study of rimabotulinumtoxinB in subjects with cervical dystonia. Int J Neurosci 120:703-710. doi: 10.3109/00207454.2010.515047
29. Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S, on behalf of the Global Dysport Cervical Dystonia Study Group (2010) Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord 16:316-323. doi: 10.1016/j.parkreldis.2010.03.002
30. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10:287-333. doi: 10.1016/j.ejpain.2005.06.009
31. Tölle T, Xu X, Sadosky AB (2006) Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complicat 20:26-33. doi: 10.1016/j.jdiacomp.2005.09.007
32. Widerström-Noga EG, Felipe-Cuervo E, Yezierski RP (2001) Chronic pain after spinal injury: interference with sleep and daily activities. Arch Phys Med Rehabil 82:1571-1577
33. Trosch R, Jozefczyk P, Truong D, Lew M, Adler C, LeWitt P, Singer C, Silay Y, Castagna A, Betts G, Marchese D, Comella C (2013) ANCHOR-CD (AbobotulinumtoxinA Neurotoxin: Clinical and Health economics Outcomes Registry in Cervical Dystonia): a multicenter, observational study of dysport in cervical dystonia: baseline data and cycle one efficacy data. Neurology 80(1-MeetingAbstracts):P07.191
34. Jankovic J, Leder S, Warner D, Schwartz K (1991) Cervical dystonia: clinical findings and associated movement disorders. Neurology 41:1088-1091